Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.

Colbath AC, Dow SW, Hopkins LS, Phillips JN, McIlwraith CW, Goodrich LR.

Equine Vet J. 2019 May 23. doi: 10.1111/evj.13136. [Epub ahead of print]

PMID:
31120574
2.

Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.

Colbath AC, Dow SW, Phillips JN, McIlwraith CW, Goodrich LR.

Stem Cells Dev. 2017 Apr 1;26(7):503-511. doi: 10.1089/scd.2016.0266. Epub 2017 Jan 12.

PMID:
27958776
3.

Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.

Joswig AJ, Mitchell A, Cummings KJ, Levine GJ, Gregory CA, Smith R 3rd, Watts AE.

Stem Cell Res Ther. 2017 Feb 28;8(1):42. doi: 10.1186/s13287-017-0503-8.

4.

Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.

Ardanaz N, Vázquez FJ, Romero A, Remacha AR, Barrachina L, Sanz A, Ranera B, Vitoria A, Albareda J, Prades M, Zaragoza P, Martín-Burriel I, Rodellar C.

BMC Vet Res. 2016 Mar 31;12:65. doi: 10.1186/s12917-016-0692-x.

5.

Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.

Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL.

Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.

PMID:
24094688
6.

Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.

Carrade DD, Owens SD, Galuppo LD, Vidal MA, Ferraro GL, Librach F, Buerchler S, Friedman MS, Walker NJ, Borjesson DL.

Cytotherapy. 2011 Apr;13(4):419-30. doi: 10.3109/14653249.2010.536213. Epub 2010 Nov 25.

PMID:
21105841
7.

Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.

Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL.

Vet Comp Orthop Traumatol. 2013;26(6):453-60. doi: 10.3415/VCOT-13-01-0008. Epub 2013 Oct 1.

PMID:
24080668
8.
9.

Addition of Mesenchymal Stem Cells to Autologous Platelet-Enhanced Fibrin Scaffolds in Chondral Defects: Does It Enhance Repair?

Goodrich LR, Chen AC, Werpy NM, Williams AA, Kisiday JD, Su AW, Cory E, Morley PS, McIlwraith CW, Sah RL, Chu CR.

J Bone Joint Surg Am. 2016 Jan 6;98(1):23-34. doi: 10.2106/JBJS.O.00407.

10.

Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.

Bertoni L, Branly T, Jacquet S, Desancé M, Desquilbet L, Rivory P, Hartmann DJ, Denoix JM, Audigié F, Galéra P, Demoor M.

Stem Cells Int. 2019 May 2;2019:9431894. doi: 10.1155/2019/9431894. eCollection 2019.

11.

The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.

Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH.

Equine Vet J. 2019 Feb 27. doi: 10.1111/evj.13089. [Epub ahead of print]

PMID:
30815897
12.

Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.

Broeckx SY, Spaas JH, Chiers K, Duchateau L, Van Hecke L, Van Brantegem L, Dumoulin M, Martens AM, Pille F.

Res Vet Sci. 2018 Apr;117:246-254. doi: 10.1016/j.rvsc.2017.12.018. Epub 2017 Dec 27.

PMID:
29329028
13.

Effects of intra-articular administration of dimethylsulfoxide on chemically induced synovitis in immature horses.

Welch RD, Watkins JP, DeBowes RM, Leipold HW.

Am J Vet Res. 1991 Jun;52(6):934-9.

PMID:
1883099
14.

The preventive effects of two nutraceuticals on experimentally induced acute synovitis.

van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA.

Equine Vet J. 2017 Jul;49(4):532-538. doi: 10.1111/evj.12629. Epub 2016 Oct 13.

15.

Induction of Synovitis Using Interleukin-1 Beta: Are There Differences in the Response of Middle Carpal Joint Compared to the Tibiotarsal Joint?

Colbath AC, Dow SW, Hopkins LS, Phillips JN, McIlwraith CW, Goodrich LR.

Front Vet Sci. 2018 Aug 31;5:208. doi: 10.3389/fvets.2018.00208. eCollection 2018.

16.

Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow-derived mesenchymal stem cells in 164 horses.

Ursini TL, Amelse LL, Elkhenany HA, Odoi A, Carter-Arnold JL, Adair HS, Dhar MS.

Equine Vet J. 2019 Mar;51(2):198-205. doi: 10.1111/evj.12992. Epub 2018 Aug 4.

PMID:
29992618
17.

Influence of an intra-articular lipopolysaccharide challenge on markers of inflammation and cartilage metabolism in young horses.

Lucia JL, Coverdale JA, Arnold CE, Winsco KN.

J Anim Sci. 2013 Jun;91(6):2693-9. doi: 10.2527/jas.2012-5981. Epub 2013 Mar 18.

PMID:
23508023
18.
19.

Intra-articular pressure, elastance, and range of motion in flexion of the equine metacarpophalangeal joint.

Strand E, Martin GS, Crawford MP, Kamerling SG, Burba DJ, Kearney MT.

Am J Vet Res. 1995 Oct;56(10):1362-71.

PMID:
8928956
20.

Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses.

Kay AT, Bolt DM, Ishihara A, Rajala-Schultz PJ, Bertone AL.

Am J Vet Res. 2008 Dec;69(12):1646-54. doi: 10.2460/ajvr.69.12.1646.

PMID:
19046013

Supplemental Content

Support Center